Abstract:Small molecules that can induce protein degradation by inducing proximity between a desired target and an E3 ligase have the potential to greatly expand the number of proteins that can be manipulated pharmacologically. Current strategies for targeted protein degradation are mostly limited in their target scope to proteins with preexisting ligands. Alternate modalities such as molecular glues, as exemplified by the glutarimide class of ligands for the CUL4CRBN ligase, have been mostly discovered serendipitously. We recently reported a trans-labelling covalent glue mechanism which we named 'Template-assisted covalent modification', where an electrophile decorated small molecule binder of BRD4 was effectively delivered to a cysteine residue on an E3 ligase DCAF16 as a consequence of a BRD4-DCAF16 protein-protein interaction. Herein, we report our medicinal chemistry efforts to evaluate how various electrophilic modifications to the BRD4 binder, JQ1, affect DCAF16 trans-labeling and subsequent BRD4 degradation efficiency. We discovered a decent correlation between the ability of the electrophilic small molecule to induce ternary complex formation between BRD4 and DCAF16 with its ability to induce BRD4 degradation. Moreover, we show that a more solvent-exposed warhead presentation is optimal for DCAF16 recruitment and subsequent BRD4 degradation. Unlike the sensitivity of CUL4CRBN glue degraders to chemical modifications, the diversity of covalent attachments in this class of BRD4 glue degraders suggests a high tolerance and tunability for the BRD4-DCAF16 interaction. This offers a potential new avenue for a rational design of covalent glue degraders by introducing covalent warheads to known binders.

Advances in molecular glues: exploring chemical space and design principles for targeted protein degradation

Molecular Glues: The Adhesive Connecting Targeted Protein Degradation to the Clinic

Molecular Glues For Targeted Protein Degradation: From Serendipity To Rational Discovery

Targeted Protein Degradation and Regulation with Molecular Glue: Past and Recent Discoveries

Molecular glue degraders: exciting opportunities for novel drug discovery

Molecular glue-mediated targeted protein degradation: A novel strategy in small-molecule drug development

Rational Design of CDK12/13 and BRD4 Molecular Glue Degraders

Charged Molecular Glue Discovery Enabled by Targeted Degron Display

Emerging strategies for prospective discovery of molecular glue degraders

Targeted protein degradation via intramolecular bivalent glues

Exploration of the Tunability of BRD4 Degradation by DCAF16 Trans-labelling Covalent Glues

Targeted Protein Degradation: Current and Emerging Approaches for E3 Ligase Deconvolution

Rational Design of Molecular Glues: Breakthroughs and Perspectives

Development of potent and selective CK1α Molecular Glue Degraders

Strengthening molecular glues: design strategies for improving thalidomide analogs as cereblon effectors and anticancer agents

Crbn-based molecular Glues: Breakthroughs and perspectives

Lessons from natural molecular glue degraders

On Ternary Complex Stability in Protein Degradation: In Silico Molecular Glue Binding Affinity Calculations

Continuous evolution of compact protein degradation tags regulated by selective molecular glues

DCAF16-Based Covalent Handle for the Rational Design of Monovalent Degraders

Molecular Glue Discovery: Current and Future Approaches.